Obsessive-compulsive symptoms with olanzapine [2]

International Journal of Neuropsychopharmacology

Volumn 7, Issue 3, 2004, Pages 375-377

  Alevizos, Basil ^a   Papageorgiou, Charalambos ^a   Christodoulou, George N ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BIPERIDEN; CLOMIPRAMINE; CLOZAPINE; FLUOXETINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM SULFATE; OLANZAPINE; PAROXETINE; RISPERIDONE; SERTRALINE; VENLAFAXINE;

ADULT; BIPOLAR DISORDER; CASE REPORT; DEPRESSION; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; LETTER; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; SCHIZOPHRENIA;

EID: 4444373326     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145704004456     Document Type: Letter

References (8)

1. Arnt J, Skarsfeldt T (1998). Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18, 63-101.
2. Bymaster FP, Calligato DO, Falcome JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT (1996). Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14, 87-96.
3. Eisen JL, Rasmussen SA (1993). Obsessive compulsive disorder with psychotic features. Journal of Clinical Psychiatry 54, 373-379.
4. 2A promotor polymorphism - 12 438 G/A, anorexia nervosa, and obsessive-compulsive disorder [Letter]. Lancet 351, 1785-1786.
5. Jonkers F, de Haan L (2002). Olanzapine-induced obsessive-compulsive symptoms in a patient with bipolar II disorder. Psychopharmacology 162, 87-88.
6. Lykouras L, Alevizos B, Michalopoulou P, Rabavilas A (2003). Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Progress in Neuro-Psychopharmacology and Biological Psychiatry 27, 333-346.
7. Poyurovsky M, Hermesh H, Weizman A (1996). Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patients. Clinical Neuropharmacology 19, 305-313.
8. Ramasubbu R, Ravindan A, Lapierre Y (2000). Serotonin and dopamine antagonism in obsessive-compulsive disorders: effect of atypical antipsychotic drugs. Pharmacopsychiatry 33, 236-238.